KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Cash from Investing Activities (2016 - 2025)

Charles River Laboratories International has reported Cash from Investing Activities over the past 17 years, most recently at -$92.8 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 21.95% year-over-year to -$92.8 million; the TTM value through Dec 2025 reached -$209.3 million, up 14.59%, while the annual FY2025 figure was -$209.3 million, 14.59% up from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$92.8 million at Charles River Laboratories International, down from -$33.7 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $44.4 million in Q4 2022 and troughed at -$954.2 million in Q2 2021.
  • A 5-year average of -$153.2 million and a median of -$82.7 million in 2023 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: tumbled 3233.31% in 2021 and later surged 376.88% in 2022.
  • Year by year, Cash from Investing Activities stood at $9.3 million in 2021, then surged by 376.88% to $44.4 million in 2022, then tumbled by 637.08% to -$238.4 million in 2023, then surged by 68.07% to -$76.1 million in 2024, then dropped by 21.95% to -$92.8 million in 2025.
  • Business Quant data shows Cash from Investing Activities for CRL at -$92.8 million in Q4 2025, -$33.7 million in Q3 2025, and -$37.3 million in Q2 2025.